Ingevity/$NGVT
1D1W1MYTD1Y5YMAX
Capital at risk
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
- Ticker
- $NGVT
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 1,500
- Headquarters
- North Charleston, United States
- Website
- www.ingevity.com
Ingevity Metrics
BasicAdvanced
$2.5B
48.18
$1.51
1.18
-
Price and volume
Market cap
$2.5B
Beta
1.18
52-week high
$79.29
52-week low
$45.85
Average daily volume
247K
Financial strength
Current ratio
1.611
Quick ratio
0.776
Long term debt to equity
23.03
Total debt to equity
26.36
Interest coverage (TTM)
4.01%
Profitability
EBITDA (TTM)
372.6
Gross margin (TTM)
41.13%
Net profit margin (TTM)
4.65%
Operating margin (TTM)
24.52%
Effective tax rate (TTM)
33.33%
Revenue per employee (TTM)
$770,000
Management effectiveness
Return on assets (TTM)
10.41%
Return on equity (TTM)
30.07%
Valuation
Price to earnings (TTM)
48.185
Price to revenue (TTM)
2.227
Price to book
53.48
Price to tangible book (TTM)
-26.65
Price to free cash flow (TTM)
16.681
Free cash flow yield (TTM)
5.99%
Free cash flow per share (TTM)
4.361
Growth
Revenue change (TTM)
-1.38%
Earnings per share change (TTM)
-125.27%
3-year revenue growth (CAGR)
-12.63%
10-year revenue growth (CAGR)
2.55%
3-year earnings per share growth (CAGR)
-31.67%
10-year earnings per share growth (CAGR)
-0.07%
What the Analysts think about Ingevity
Analyst ratings (Buy, Hold, Sell) for Ingevity stock.
Analyst projections of the future price of Ingevity stock.
Bulls say / Bears say
Ingevity’s operating momentum is broadening. Second-quarter adjusted EBITDA rose 14% to $115 million, margins expanded to 36.6%, and management raised its 2026 adjusted EBITDA and EPS guidance after excluding the divested Road Markings business. (Business Wire, The Motley Fool)
Portfolio simplification is improving the quality of the remaining business. After selling Industrial Specialties and Road Markings, Ingevity says its core Performance Materials and Pavement Technologies businesses are less cyclical, while net leverage has fallen to 2.5 times from 3.0 times a year earlier. (Stock Analysis, Ingevity)
Ingevity has a credible adjacent growth option in water treatment. A recent municipal contract for PFAS filtration provides early commercial validation for using its differentiated carbon technology outside automotive emissions control. (Last10K)
The second half carries clear execution risk: Ingevity expects weaker North American auto production and planned maintenance outages at two Performance Materials facilities. That could pressure the high-margin carbon segment even after the raised full-year outlook. (The Motley Fool)
Advanced Polymer Technologies’ improvement may not be fully repeatable: its second-quarter gains were helped by competitor supply disruptions and a better product mix. The business is also being marketed for sale, so normalisation of competitors’ supply or a disappointing transaction could remove a recent earnings tailwind. (MarketBeat, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 19 Sept 2026.
Ingevity Financial Performance
Revenues and expenses
Ingevity Earnings Performance
Company profitability
Upcoming events
No upcoming events
Ingevity News
AllArticlesVideos
Funds containing Ingevity
AllUSDGBPEUR
Fund name | Fund size | $NGVT weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.14% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.14% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.09% |
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.